Kathy Harrison
Chief Executive Officer
Clinuvel Pharmaceuticals
Australia
Biography
Kathy has more than 20 years experience within the Australian Biotech Industry, focussing on commercialisation of company IP assets. Previously, Kathy has worked within ASX listed companies AMRAD Biotech, Cytopia Research Pty Ltd, and Phosphagenics Limited, in a wide variety of functions such as product development, clinical development, document control and IP strategy and management. Kathy has held various corporate responsibilities such as management of human resources, scheme of arrangement merger due diligence and R&D tax incentive applications. Kathy also spent 9 years in private practice as a patent and trade mark attorney at Watermark, gaining a wealth of experience in the legal framework underscoring commercialisation of technologies. Kathy holds a Master of Science from Manchester University (UK), a Certificate in Governance (Practice) from the Governance Institute of Australia, and is a Registered Patent and Trade Mark Attorney in Australia and Fellow of the Institute of Patent and Trade Mark Attorneys.
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management
